-+ 0.00%
-+ 0.00%
-+ 0.00%

DESIGN THERAPEUTICS INC - DT-216P2 GENERALLY WELL-TOLERATED WITH NO SERIOUS ADVERSE EVENTS REPORTED

Reuters·05/18/2026 11:00:02

Please log in to view news